Acquired hemophilia a hemostatic treatment with recombinant porcine factor VIII

被引：0
|
作者：
Sobolewska, A. [2 ]
Urbanska, A. [2 ]
Bednarska, M. [2 ]
Zawadzka, I. [2 ]
Witkowski, M. [1 ]
机构：
[1] Copernicus Mem Hosp, Dept Gen Haematol, Lodz, Poland
[2] Med Lab Synevo Copernicus, Lodz, Poland
来源：
CLINICA CHIMICA ACTA | 2024年 / 558卷
关键词：
D O I：
10.1016/j.cca.2024.118418
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
P1400
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of B-domain deleted recombinant porcine factor VIII (OBI-1) in the treatment of acquired hemophilia A: interim results
    Greist, A.
    Shapiro, A.
    Kruse-Jarres, R.
    St Louis, J.
    Smith, H.
    Gomperts, E.
    HAEMOPHILIA, 2012, 18 : 1 - 1
  • [22] The in vitro cross-reactivity and blood coagulation potential of recombinant porcine factor VIII in Japanese patients with acquired hemophilia A
    Takeyama, Masahiro
    Sasai, Kana
    Miyaguchi, Yasuo
    Ogiwara, Kenichi
    Furukawa, Shoko
    Shimonishi, Naruto
    Nakajima, Yuto
    Ueda, Hitoshi
    Nogami, Keiji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2025, 121 (01) : 45 - 55
  • [23] Cyclosporine treatment of acquired hemophilia due to factor VIII antibodies
    Petrovic, M
    Derom, E
    Baele, G
    HAEMATOLOGICA, 2000, 85 (08) : 895 - 896
  • [24] A Case Report of a Recombinant Porcine Factor VIII Usage in Acquired Haemophilia A
    Ewins, K. T.
    Singleton, E.
    Byrne, M.
    O'Connell, N.
    Ryan, K.
    HAEMOPHILIA, 2017, 23 : 91 - 92
  • [25] Treatment of acquired haemophilia with recombinant porcine factor VIII: A successful strategy in a patient with unstable angina
    Owen, Mary
    Gidley, Gillian
    Horn, Elizabeth H.
    HAEMOPHILIA, 2019, 25 (02) : E94 - E97
  • [26] Short-term efficacy of recombinant porcine factor VIII in patients with acquired factor VIII inhibitors
    Abou-Ismail, M.
    Vuyyala, S.
    Prunty, J.
    Schmaier, A.
    Nayak, L.
    HAEMOPHILIA, 2019, 25 : 3 - 3
  • [27] Recombinant factor VIII: past, present and future of treatment of hemophilia A
    Raso, S.
    Hermans, C.
    DRUGS OF TODAY, 2018, 54 (04) : 269 - 281
  • [28] Pharmacokinetic drug evaluation of recombinant factor VIII for the treatment of hemophilia A
    Castaman, Giancarlo
    Linari, Silvia
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (02) : 143 - 151
  • [29] Treatment and Prophylaxis of Hemophilia A Progress with Improved Recombinant Factor VIII
    Gruetzner, Karen
    THROMBOSIS AND HAEMOSTASIS, 2016, 116 (03) : 191 - 192
  • [30] RECOMBINANT FACTOR-VIII IN HEMOPHILIA
    COHEN, A
    BUTLER, R
    NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (21): : 1515 - 1516
12345